Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmissionCLINICAL MICROBIOLOGY AND INFECTIONIF8.52022-01-0120OA
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansNature MicrobiologyIF19.42020-10-260PREAI
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsPLOS PATHOGENSIF4.92020-09-2482OAAI
Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndromeANALYSTIF3.32020-01-0120OAAI
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in MelanomaFRONTIERS IN IMMUNOLOGYIF5.92019-03-19197OAAI